Through these lines of inquiry, we hope to uncover treatments that will substantially improve vascular dysfunction during sepsis and other states of systemic inflammation by restoring EG integrity and/or attenuating pathologic Ang-2 production. The gene discussed is ANGPT2; the disease is Sepsis.